NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
NOTE
1 – BASIS OF PRESENTATION
These
consolidated financial statements of Graphene & Solar Technologies Limited (GSTX or the Company) have been prepared in accordance
with accounting principles generally accepted in the United States of America (U.S. GAAP). In the opinion of management, these financial
statements include all adjustments, consisting only of normal recurring adjustments, necessary for a fair statement of the results for
the interim periods. Certain information, accounting policies and footnote disclosures normally included in financial statements prepared
in accordance with U.S. GAAP have been omitted pursuant to Securities and Exchange Commission (SEC) rules and regulations. These financial
statements should be read along with Graphene & Solar’s audited financial statements as of September 30, 2022.
Going
Concern – The Company has incurred cumulative net losses since inception of $67,246,472 December 31, 2022. Accordingly, it
requires capital to fund working capital deficits and for future operating activities to take place. The Company’s ability to raise
new funds through the future issuances of debt or common stock is unknown. The obtainment of additional financing, the successful development
of a plan of operations, and its transition, ultimately, to the attainment of profitable operations are necessary for the Company to
continue operations. The ability of the Company to continue its operations is dependent on management’s plans, which include the
raising of capital through debt and/or equity markets, with some additional funding from other traditional financing sources, including
term notes, until such time that funds provided by operations are sufficient to fund working capital requirements. The Company may need
to incur additional liabilities with certain related parties to sustain the Company’s existence. There can be no assurance that
the Company will be able to raise any additional capital and therefore raise doubt about the Company’s ability to continue as a
going concern.
Future
issuances of the Company’s equity or debt securities will be required for the Company to finance operations and continue as a going
concern. The financial statements do not include any adjustments that may result from the outcome of these uncertainties.
NOTE
2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PRESENTATION
Principles
of Consolidation and Basis of Presentation — The consolidated financial statements include the accounts of Graphene & Solar
Technologies Limited and its subsidiary. All significant intercompany accounts and transactions have been eliminated in consolidation.
The
accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States
of America (“GAAP”) and pursuant to the accounting and disclosure rules and regulations of the U.S. Securities and Exchange
Commission (“SEC”). A summary of the significant accounting policies applied in the preparation of the accompanying financial
statements can be found in the Company’s Annual Report in form 10-K for the year ended September 30, 2022.
Use
of Estimates - The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions
that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial
statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Significant
estimates include but are not limited to the estimated useful lives of equipment for purposes of depreciation and the valuation of common
shares issued for services, equipment and the liquidation of liabilities.
Cash
and Cash Equivalents - Cash and cash equivalents are carried at cost and represent cash on hand, demand deposits placed with banks
or other financial institutions and all highly liquid investments with an original maturity of three months or less as of the purchase
date of such investments. As of December 31, 2022 and September 30, 2022, the Company had $13,076 and $2,857 in cash, respectively and
no cash equivalents.
Derivative
Financial Instruments - The Company accounts for freestanding contracts that are settled in a company’s own stock, including
common stock warrants, to be designated as an equity instrument or generally as a liability. A contract so designated is carried at fair
value on a company’s balance sheet, with any changes in fair value recorded as a gain or loss in a company’s results of operations.
The
Company records all derivatives on the balance sheet at fair value, adjusted at the end of each reporting period to reflect any material
changes in fair value, with any such changes classified as changes in derivatives valuation in the statement of operations. The calculation
of the fair value of derivatives utilizes highly subjective and theoretical assumptions that can materially affect fair values from period
to period. The recognition of these derivative amounts does not have any impact on cash flows.
At
the date of the conversion of any convertible debt, the pro rata fair value of the related embedded derivative liability is transferred
to additional paid-in capital.
There
was no derivative activity in fiscal quarter ending December 31, 2022. Therefore, no derivative liabilities were recorded during the
quarter ended December 31, 2022.
Stock-Based
Compensation - ASC 718, “Compensation - Stock Compensation,” prescribes accounting and reporting standards for
all share-based payment transactions in which employee and non-employee services are acquired. Transactions include incurring liabilities,
or issuing or offering to issue shares, options, and other equity instruments such as employee stock ownership plans and stock appreciation
rights. Share-based payments to employees and non-employees, including grants of employee stock options, are recognized as compensation
expense in the financial statements based on their fair values on the grant date. That expense is recognized over the period during which
an employee is required to provide services in exchange for the award, known as the requisite service period (usually the vesting period).
During
the quarter ended December 31, 2022, the Company did not issue any shares of the Company’s common stock to members of the Board
of Directors, employees, and consultants.
During
the quarter ended December 31, 2021, the Company issued 18,386,364 shares of the Company’s common stock to members of the Board
of Directors, employees, and consultants. The fair value of the shares, as determined by reference market price of the Company’s
common stock on each grant date, aggregated $12,382,500.
Total
stock-based compensation expense was $0 and $12,382,500 for the quarters ended December 31, 2022 and 2021, respectively, of which $9,485,000
(13,500,000 shares) were issued to directors and considered related parties.
Foreign
Currency Translations – The functional currency of the Company’s foreign subsidiary is primarily the respective local
currency. Assets and liabilities of the Company’s foreign subsidiary are translated into U.S. Dollars at the year-end exchange
rate, and revenues and expenses are translated at average monthly exchange rates. Translation gains and losses are recorded as a component
of accumulated other comprehensive income (loss) within stockholders’ equity. All other foreign currency transaction gains and
losses are included in other (income) expense, net.
Earnings
Per Share - Basic earnings per share have been calculated based upon the weighted-average number of common shares outstanding. Diluted
earnings per share were not calculated as such potential shares would be anti-dilutive.
Reclassifications
- Certain amounts previously presented for prior periods have been reclassified to conform to the current presentation. The reclassifications
had no effect on net loss, working capital or equity previously reported.
NOTE
3 – NOTES PAYABLE
The
Company’s indebtedness as of December 31, 2022 and September 30, 2022 were as follows:
Schedule
of Notes Payable
|
|
|
|
|
Description |
|
December
31, 2022 |
|
September
30, 2022 |
|
|
|
|
|
Convertible
notes |
|
$ |
100,747 |
|
|
$ |
100,747 |
|
Notes
Payable |
|
$ |
76,938 |
|
|
$ |
76,255 |
|
Related
party loans |
|
|
20,000 |
|
|
|
— |
|
Notes
Payable and Other Loans
During
2015 and 2016, the Company executed promissory notes payable with six individuals with an aggregate principal balance of $60,000. The
notes were due on demand and included interest at 10%. As of December 31, 2022 and September 30, 2022, the total promissory notes payable
balance was $104,222 and $118,965 including accrued interest of $44,222 and $42,710, respectively. On January 15, 2019, the holder of
a note with a principal balance of $10,000 made demand for payment. To date, the note has not been paid.
During
the year ended September 30, 2020 a Company Advisor, loaned the Company $5,811. The loan is a demand note at zero interest.
Convertible
Notes Payable
As
of December 31, 2022 and September 30, 2022, noteholders representing $70,747 in outstanding principal had not requested the exchange
of shares of common stock. As of December 31, 2022 and September 30, 2022, the exchange obligation payable was $171,572 and $168,897
including accrued interest of $100,825 and $98,150, respectively. As of December 31, 2022 and September 30, 2022, the exchange obligation
was for 51,834 shares and 51,026 shares of common stock, respectively.
On
February 1, 2016, the Company issued convertible secured note payable of $30,000 to an individual. The note was due on January 31, 2017
and included interest at 10%. The note was convertible at discretion of the holder into common shares of the Company at the rate of $0.50
per shares. The Company has not extended the maturity date and the note is in default. As of December 31, 2022 and September 30, 2022,
the total convertible note payable balance was $50,753 and $49,997, including accrued interest of $20,753 and $19,997 respectively. As
of December 31, 2022 and September 30, 2022, the exchange obligation was for 101,506 shares and 99,994 shares of common stock, respectively.
Related
Party Loans
On
December 5, 2022, the Company entered into a Promissory Loan Note with Mr. Andrew Liang, in the amount of US$20,000, with a maturity
date of December 5, 2023. The loan will accrue interest at the rate of 10% per annum.
NOTE
4- RELATED PARTY
CSA
Liang Pty Ltd, a management company controlled by the Company’s Chief Executive Officer, and a Company Director, provides management
services to the Company for which the Company is charged $20,833 monthly. During the three months ended Dec 31, 2022, the Company incurred
charges to operations of $62,499 with respect to this arrangement.
On
October 1, 2022, Mr. Andrew Liang signed a formal agreement with the Company to perform services of a Chief Executive Officer. Mr. Liang
shall be issued 30,000,000 shares at the start of the contract. This is calculated as 10,000,000 shares for every year of this consulting
agreement. Should the contract be terminated early, then the company has the right to purchase back a pro-rata portion of the 30,000,000
shares based on time served out of the 36-month contract. As of this filing date, the 30,000,000 shares have been approved but remain
unissued.
During
the quarters ended December 31, 2022 and 2021, stock-based compensation expense relating to directors, officers, affiliates and related
parties was $0 (no shares) and $2,485,000 (3,500,000
shares), respectively.
NOTE
5 – STOCKHOLDERS’ EQUITY
No
common shares were issued during the quarter ended December 31, 2022. The Company has a total of 5,778,367 shares that remain approved,
reserved and outstanding and not yet issued by the Transfer Agent at December 31, 2022.
NOTE
6 – INTANGIBLE ASSETS/PATENTS
We
amortize capitalized patent costs for internally generated patents on a straight-line basis for 7 years, which represents the estimated
useful lives of the patents. The seven-year estimated useful life for internally generated patents is based on our assessment of
such factors as: the integrated nature of the portfolios being licensed, the overall makeup of the portfolio over time, and the length
of license agreements for such patents. The estimated useful lives of acquired patents and patent rights, however, have been and will
continue to be based on a separate analysis related to each acquisition and may differ from the estimated useful lives of internally
generated patents. The average estimated useful life of acquired patents is 6.7 years. We assess the potential impairment to
all capitalized net patent costs when events or changes in circumstances indicate that the carrying amount of our patent portfolio may
not be recoverable.
Schedule
of Finite Lived Intangible Assets
| |
| |
|
| |
December 31, 2022 | |
September 30, 2022 |
Patents | |
| 1 | | |
| 6,777,424 | |
Accumulated amortization | |
| — | | |
| (982,821 | ) |
Total patent costs, net | |
| 1 | | |
| 1 | |
NOTE
7 – SUBSEQUENT EVENTS
On April 1, 2023, Mr. Jason May was appointed Chief Executive Officer by the Board of Directors. Mr. Andrew Liang has stepped down from the CEO role but remains a Director on the Board. Mr. May was granted 2,000,000 shares per the terms of the agreement. As of this filing date, the 2,000,000 shares have been approved but remain unissued. On April 1, 2023, Mr. Charles Wantrup was appointed Corporate Secretary by the Board of Directors. Mr. Thomas Chang was granted a maximum of 1,000,000 shares per annum subject to performance in fiscal years 2021/2022, 2022/2023 and 2023/2024 to a total of 3,000,000 shares. 1,000,000 shares were issued during the 2021/2022 fiscal year. As of this filing date, the remaining 2,000,000 shares have been approved but remain unissued.
On February 28, 2023, the Company entered into a Promissory Loan Note with MI Labs Pty Ltd, in the amount of US$50,000, with a maturity date of February 28, 2024. The loan will accrue interest at the rate 10% per annum.
On March 29, 2023, the Company issued 67,750 shares to settle accounts payable debt.
On March 29, 2023, the Company issued 169,380 shares for the settlement of debt totaling $16,938.
On April 1, 2023, Mr. Arnold Sock signed a services agreement with the Company and was issued 5,000,000 shares per the terms of the agreement.
On April 12, 2023, Mr. Raymond Purdon signed a consulting agreement with the Company and was issued 5,000,000 shares per the terms of the agreement.
On April 27, 2023, Brookside Communications signed a consulting agreement with the Company and was issued 250,000 shares per the terms of the agreement.